120 related articles for article (PubMed ID: 17521863)
1. Cytotoxicity of peroxisome proliferator-activated receptor alpha and gamma agonists in renal proximal tubular cell lines.
Giral H; Villa-Bellosta R; Catalán J; Sorribas V
Toxicol In Vitro; 2007 Sep; 21(6):1066-76. PubMed ID: 17521863
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Chana RS; Lewington AJ; Brunskill NJ
Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
[TBL] [Abstract][Full Text] [Related]
3. Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu KK; Bhatt R; Kaushal GP; Portilla D
Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.
Strakova N; Ehrmann J; Bartos J; Malikova J; Dolezel J; Kolar Z
Neoplasma; 2005; 52(2):126-36. PubMed ID: 15800711
[TBL] [Abstract][Full Text] [Related]
5. Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
Kwon CH; Yoon CS; Kim YK
Toxicology; 2008 Feb; 244(1):13-24. PubMed ID: 18082925
[TBL] [Abstract][Full Text] [Related]
6. Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma.
Rau O; Syha Y; Zettl H; Kock M; Bock A; Schubert-Zsilavecz M
Arch Pharm (Weinheim); 2008 Mar; 341(3):191-5. PubMed ID: 18275039
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Atarod EB; Kehrer JP
Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193
[TBL] [Abstract][Full Text] [Related]
8. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
9. Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.
Sekulic-Jablanovic M; Petkovic V; Wright MB; Kucharava K; Huerzeler N; Levano S; Brand Y; Leitmeyer K; Glutz A; Bausch A; Bodmer D
PLoS One; 2017; 12(11):e0188596. PubMed ID: 29182629
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
Knight B; Yeap BB; Yeoh GC; Olynyk JK
Carcinogenesis; 2005 Oct; 26(10):1782-92. PubMed ID: 15917308
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
[TBL] [Abstract][Full Text] [Related]
12. Two thiophenes compounds are partial peroxisome proliferator-activated receptor α/γ dual agonists.
Zheng Z; Yang Y; Shao H; Liu Z; Lu X; Xu Y; He X; Jiang W; Jiang Q; Zhao B; Zhang H; Li Z; Si S
Biol Pharm Bull; 2011; 34(10):1631-4. PubMed ID: 21963508
[TBL] [Abstract][Full Text] [Related]
13. PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents.
Lanne B; Dahllöf B; Lindahl C; Ebefors K; Kanmert I; von Bahr H; Miliotis T; Nyström AC; Arnerup G; Paulsons I; Kerb S; Oakes N
J Proteome Res; 2006 Aug; 5(8):1850-9. PubMed ID: 16889406
[TBL] [Abstract][Full Text] [Related]
14. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.
Sivarajah A; Chatterjee PK; Hattori Y; Brown PA; Stewart KN; Todorovic Z; Mota-Filipe H; Thiemermann C
Med Sci Monit; 2002 Dec; 8(12):BR532-9. PubMed ID: 12503032
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
Li X; Kimura H; Hirota K; Sugimoto H; Kimura N; Takahashi N; Fujii H; Yoshida H
Nephrol Dial Transplant; 2007 Apr; 22(4):1041-51. PubMed ID: 17255125
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice.
El-Jamal N; Dubuquoy L; Auwerx J; Bertin B; Desreumaux P
Exp Dermatol; 2013 Feb; 22(2):137-40. PubMed ID: 23362873
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of PPARα normalizes the skin lipid ratio and improves the skin barrier of normal and filaggrin deficient reconstructed skin.
Wallmeyer L; Lehnen D; Eger N; Sochorová M; Opálka L; Kováčik A; Vávrová K; Hedtrich S
J Dermatol Sci; 2015 Nov; 80(2):102-10. PubMed ID: 26472199
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma.
Chana RS; Brunskill NJ
Am J Nephrol; 2006; 26(1):67-74. PubMed ID: 16508249
[TBL] [Abstract][Full Text] [Related]
20. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
